Literature DB >> 10950878

CFTR, MDR1, and MRP1 immunolocalization in normal human nasal respiratory mucosa.

M A Wioland1, J Fleury-Feith, P Corlieu, F Commo, G Monceaux, J Lacau-St-Guily, J F Bernaudin.   

Abstract

CFTR (cystic fibrosis transmembrane conductance regulator), MDR1 (multidrug resistance), and MRP1 (multidrug resistance-associated protein), members of the ABC transporter superfamily, possess multiple functions, particularly Cl(-), anion, and glutathione conjugate transport and cell detoxification. They are also hypothesized to have a number of complementary functions. It is generally accepted that data obtained from nasal mucosa can be extrapolated to lower airway cell physiology. The aim of the present study was to investigate by immunohistochemistry the differential localization of CFTR, MDR1, and MRP1 in the normal mucosa of 10 human nasal turbinates. In ciliated epithelial cells, CFTR was inconstantly expressed at the apical cell surface, intense membranous labeling was observed for MDR1, and intense cytoplasmic labeling was observed for MRP1. In the glands, a higher level of expression was observed on serous cells, at the apical surface (for CFTR), on lateral membranes (for MDR1), and with an intracytoplasmic distribution (for MRP1). In conclusion, CFTR, MDR1 and MRP1 are expressed in the epithelium and glands of the nasal respiratory mucosa, but with different patterns of expression. These results suggest major roles for CFTR, MDR1, and MRP1 in serous glandular cells and a protective function for MDR1 and MRP1 in respiratory ciliated cells. (J Histochem Cytochem 48:1215-1222, 2000)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10950878     DOI: 10.1177/002215540004800905

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  18 in total

1.  Intranasal application of vasopressin fails to elicit changes in brain immediate early gene expression, neural activity and behavioural performance of rats.

Authors:  M Ludwig; V A Tobin; M F Callahan; E Papadaki; A Becker; M Engelmann; G Leng
Journal:  J Neuroendocrinol       Date:  2013-07       Impact factor: 3.627

Review 2.  Is RPMI 2650 a Suitable In Vitro Nasal Model for Drug Transport Studies?

Authors:  Clément Mercier; Nathalie Perek; Xavier Delavenne
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-02       Impact factor: 2.441

3.  The characterization of the human nasal epithelial cell line RPMI 2650 under different culture conditions and their optimization for an appropriate in vitro nasal model.

Authors:  Mateja Erdani Kreft; Urška Dragin Jerman; Eva Lasič; Tea Lanišnik Rižner; Neli Hevir-Kene; Luka Peternel; Katja Kristan
Journal:  Pharm Res       Date:  2014-08-22       Impact factor: 4.200

4.  Functional evidence for P-glycoprotein at the nose-brain barrier.

Authors:  Candace L Graff; Gary M Pollack
Journal:  Pharm Res       Date:  2005-01       Impact factor: 4.200

5.  Microarray Determination of the Expression of Drug Transporters in Humans and Animal Species Used for the Investigation of Nasal Absorption.

Authors:  Manar Al-Ghabeish; Todd Scheetz; Mahfoud Assem; Maureen D Donovan
Journal:  Mol Pharm       Date:  2015-07-10       Impact factor: 4.939

Review 6.  Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1).

Authors:  Eva Bakos; László Homolya
Journal:  Pflugers Arch       Date:  2006-12-23       Impact factor: 3.657

7.  Pharmacokinetics of substrate uptake and distribution in murine brain after nasal instillation.

Authors:  Candace L Graff; Rong Zhao; Gary M Pollack
Journal:  Pharm Res       Date:  2005-02       Impact factor: 4.200

8.  The cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in maturation stage ameloblasts, odontoblasts and bone cells.

Authors:  Antonius Bronckers; Lida Kalogeraki; Huub J N Jorna; Martina Wilke; Theodore J Bervoets; Donacian M Lyaruu; Behrouz Zandieh-Doulabi; Pamela Denbesten; Hugo de Jonge
Journal:  Bone       Date:  2009-12-30       Impact factor: 4.398

9.  Concentrations of h1-receptor antagonist in the human nasal mucosa.

Authors:  Kenji Takasaki; Kaori Enatsu; Hidetaka Kumagami; Haruo Takahashi
Journal:  Int J Otolaryngol       Date:  2009-11-25

10.  P-Glycoprotein attenuates brain uptake of substrates after nasal instillation.

Authors:  Candace L Graff; Gary M Pollack
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.